Core Insights - The company, MicroPort Robotics, has achieved a significant milestone by becoming the first and only company globally to commercialize a full range of surgical robots, with a total of 7 products approved for market since January 2022 [2][3] - The company has successfully broken the 20-year monopoly of foreign products in the surgical robot field, reshaping the global market landscape [2][3] Product Development - The latest product, a bronchoscopic surgical robot, has received approval from the National Medical Products Administration, bringing the total number of approved surgical robots to 7 [3] - The first product, the TUMI laparoscopic surgical robot, was approved in January 2022, ending the monopoly of the Da Vinci system in this field, with over 160 global orders and more than 100 commercial installations [3] - The orthopedic surgical robot, Honghu, was approved shortly after TUMI and has entered multiple overseas markets, with some hospitals in Germany fully adopting it for joint replacement surgeries [3] Financial Performance - In the first half of 2025, the company reported revenue of 176 million yuan, a year-on-year increase of 77%, and significantly reduced losses by 59% [4] - The company achieved overseas revenue of 103 million yuan, a 189% increase year-on-year, accounting for approximately 60% of total revenue [6] Market Strategy - The company is accelerating its international market expansion, having made significant breakthroughs in Europe, Latin America, the Middle East, Southeast Asia, and Africa [6] - The domestic market is still dominated by Da Vinci, but the share of domestic brands is expected to reverse starting in 2024, indicating substantial growth potential for local brands [6] Innovation and Industry Challenges - The company emphasizes the need for innovation and unique value in the surgical robot industry, having completed the world's first autonomous surgery using AI technology [7] - There is a call for improved policies and market mechanisms to support the healthy development of the industry, particularly for original technology and innovative products [7][8]
微创机器人重塑全球手术机器人市场格局——专访微创机器人创始人、首席执行官何超博士